Technical Analysis for ATXI - Avenue Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 4.7466 -0.07% 0.00
ATXI closed down 0.07 percent on Friday, May 24, 2019, on 86 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical ATXI trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Inside Day Range Contraction 0.00%
50 DMA Resistance Bearish -0.07%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.07%
Spinning Top Other -0.07%
Outside Day Range Expansion -0.07%

Older signals for ATXI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for the management of moderate to moderately severe postoperative pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Tramadol is also combined with acetaminophen (APAP) or nonsteroidal anti-inflammatory drugs (NSAIDS) in clinical practice. During the year ending December 31, 2016, the Company had completed a pharmacokinetics (PK) study for IV Tramadol in healthy volunteers.
Pharmaceutical Drugs Chemical Compounds Analgesics Pharmacokinetics Hepatotoxins Neurochemistry Amines Opioid Paracetamol
Is ATXI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.82
52 Week Low 2.08
Average Volume 20,697
200-Day Moving Average 4.6383
50-Day Moving Average 4.8453
20-Day Moving Average 4.6512
10-Day Moving Average 4.6988
Average True Range 0.2405
ADX 14.39
+DI 14.4228
-DI 14.8178
Chandelier Exit (Long, 3 ATRs ) 4.3285
Chandelier Exit (Short, 3 ATRs ) 4.8515
Upper Bollinger Band 4.9279
Lower Bollinger Band 4.3745
Percent B (%b) 0.67
BandWidth 11.898005
MACD Line -0.0208
MACD Signal Line -0.0558
MACD Histogram 0.035
Fundamentals Value
Market Cap 47.66 Million
Num Shares 10 Million
EPS -0.44
Price-to-Earnings (P/E) Ratio -10.79
Price-to-Sales 0.00
Price-to-Book 1.57
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.89
Resistance 3 (R3) 4.88 4.83 4.87
Resistance 2 (R2) 4.83 4.79 4.83 4.86
Resistance 1 (R1) 4.79 4.77 4.76 4.79 4.85
Pivot Point 4.73 4.73 4.72 4.73 4.73
Support 1 (S1) 4.69 4.69 4.66 4.70 4.64
Support 2 (S2) 4.64 4.67 4.64 4.64
Support 3 (S3) 4.60 4.64 4.63
Support 4 (S4) 4.60